Unknown

Dataset Information

0

KRAS and CREBBP mutations: a relapse-linked malicious liaison in childhood high hyperdiploid acute lymphoblastic leukemia.


ABSTRACT: High hyperdiploidy defines the largest genetic entity of childhood acute lymphoblastic leukemia (ALL). Despite its relatively low recurrence risk, this subgroup generates a high proportion of relapses. The cause and origin of these relapses remains obscure. We therefore explored the mutational landscape in high hyperdiploid (HD) ALL with whole-exome (n=19) and subsequent targeted deep sequencing of 60 genes in 100 relapsing and 51 non-relapsing cases. We identified multiple clones at diagnosis that were primarily defined by a variety of mutations in receptor tyrosine kinase (RTK)/Ras pathway and chromatin-modifying genes. The relapse clones consisted of reappearing as well as new mutations, and overall contained more mutations. Although RTK/Ras pathway mutations were similarly frequent between diagnosis and relapse, both intergenic and intragenic heterogeneity was essentially lost at relapse. CREBBP mutations, however, increased from initially 18-30% at relapse, then commonly co-occurred with KRAS mutations (P<0.001) and these relapses appeared primarily early (P=0.012). Our results confirm the exceptional susceptibility of HD ALL to RTK/Ras pathway and CREBBP mutations, but, more importantly, suggest that mutant KRAS and CREBBP might cooperate and equip cells with the necessary capacity to evolve into a relapse-generating clone.

SUBMITTER: Malinowska-Ozdowy K 

PROVIDER: S-EPMC4530204 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

altmetric image

Publications


High hyperdiploidy defines the largest genetic entity of childhood acute lymphoblastic leukemia (ALL). Despite its relatively low recurrence risk, this subgroup generates a high proportion of relapses. The cause and origin of these relapses remains obscure. We therefore explored the mutational landscape in high hyperdiploid (HD) ALL with whole-exome (n=19) and subsequent targeted deep sequencing of 60 genes in 100 relapsing and 51 non-relapsing cases. We identified multiple clones at diagnosis t  ...[more]

Similar Datasets

| S-EPMC4194312 | biostudies-literature
2019-02-25 | PXD010175 | Pride
| S-EPMC3003126 | biostudies-literature
2020-01-29 | MSV000084862 | MassIVE
| S-EPMC6447538 | biostudies-literature
| S-EPMC5367703 | biostudies-literature
| S-EPMC3681285 | biostudies-literature
| S-EPMC7374087 | biostudies-literature
| S-EPMC8247877 | biostudies-literature
| S-EPMC5547099 | biostudies-literature